Xerox, Hubbell, Spotify And Other Big Stocks Moving Higher On Tuesday

U.S. stocks traded lower, with the Nasdaq Composite dropping around 100 points on Tuesday. Here are some big stocks recording gains in today’s session.

• Morphic Holding, Inc. MORF shares jumped 20.8% to $52.50 after the company announced that its open-label EMERALD-1 Phase 2a study of MORF-057 met its primary endpoint in adults with moderate to severe ulcerative colitis.
• Arrowhead Pharmaceuticals, Inc. ARWR rose 17.2% to $35.19 after the company announced interim results from an ongoing Phase 1/2 clinical study of ARO-RAGE.
• Medpace Holdings, Inc. MEDP climbed 16.5% to $218.06 after the company reported better-than-expected Q1 results.
• Aaron's Company Inc AAN rose 15.6% to $11.81 after the company reported Q1 results and updated full-year guidance.
• Edgewise Therapeutics, Inc. EWTX gained 14.4% to $8.24.
• Xerox Holdings Corporation XRX surged 13% to $15.36 following upbeat quarterly earnings.
• Simpson Manufacturing Co., Inc. SSD rose 11.6% to $126.05 following better-than-expected quarterly results.
• Hubbell Incorporated HUBB climbed 10.4% to $256.73 following strong quarterly results.
• PureCycle Technologies, Inc. PCT gained 10.2% to $5.72.
• Gambling.com Group Limited GAMB rose 7.1% to $10.40 after announcing select preliminary 2023 Q1 results.
• Apollomics, Inc. APLM gained 6.7% to $4.31 after EF Hutton initiated coverage on the stock with a Buy rating and a $25 price target.
• Allogene Therapeutics, Inc. ALLO jumped 6.2% to $5.70.
• bluebird bio, Inc. BLUE rose 5.6% to $3.6350. Bluebird Bio said it submitted its Biologics License Application to the FDA for lovotibeglogene autotemcel for patients with sickle cell disease ages 12 and older with a history of vaso-occlusive events.
• Spotify Technology S.A. SPOT gained 4.5% to $137.39 after the company reported Q1 financial results. Total revenue grew 14% year over year and Monthly Active Users grew by 22% year over year.

Read More: Bitcoin, Ethereum Record Losses; PancakeSwap Becomes Top Loser